Work

Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients

Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Galohgor nutraceutical (GN) is a polyherbal product from the Sundanese ethnic group in Indonesia. GN contains antioxidants and other bioactive compounds that have shown synergistic effects in controlling blood glucose in animal models and significantly decreasing oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM). The aim of this study was to analyze the effect of GN on the fasting blood glucose (FBG) levels of T2DM subjects. A quasi-experimental pre-post-controlled trial design was conducted with 26 subjects divided into two groups: intervention and control. One subject from the control group and 6 from the GN group were excluded due to illness or voluntary withdrawal. The study was conducted in the Bogor District, West Java, over a 38-day intervention period. The formulation of the GN cookies and powdered drinks in the intervention group was similar to the control group, but supplemented with 2 g of GN powder daily, which was added in 24 g of cookies (containing 1 g of GN/serving size) and one pack of powdered drinks (containing 1 g of GN/serving size). The study received ethical approval (No.422/III/LPPM-PM.10.05/05/2016). Physical activity was measured using the International Physical Activity Questionnaire (IPAQ). Food intake data were obtained via a 24-h food record and recall combination at the beginning and during the intervention. The frequency of high glycemic index (GI) carbohydrate consumption was measured using a semi-quantitative food frequency questionnaire (SQ-FFQ). Differences in FBG between groups were tested using ANCOVA. At baseline, the FBG levels of the GN intervention and control groups were 267.5 mg/dL and 241.5 mg/dL, respectively. FBG significantly decreased in the GN intervention group compared to the control group (p<0.015). This study was limited by its quasi-experimental pre-post design and small sample size which may have introduced selection bias and limited generalizability. To elaborate on the potential effects and mechanisms of GN as an antidiabetic agent, further studies should be conducted with larger, randomized T2DM cohorts using standardized GN products.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7225891006
FWCI:
Cites: 24
Cited by:
Related to: 10